HERTI 440MG INJ VIAL

Salt Composition: TRASTUZUMAB  
Manufacturer: HT- HETERO HEALTHCARE LTD.  
0 0 11
MRP
:
54,266
Price
:
18,980
You Save
:
35,286 (65%)
In Stock
H1MQ2124I8
   Check delivery options  
 
Share: 

About

Herti 440mg Injection contains Trastuzumab as its active ingredient and is primarily used to treat HER2-positive breast cancer. In these patients, cancer cells have high levels of the HER2 protein, which promotes rapid tumor growth by sending continuous signals that encourage cancer cell proliferation. Herti is also prescribed for treating metastatic gastric cancer in patients with elevated HER2 protein levels.

HER2-positive breast cancers are typically more aggressive. This medication functions as a targeted therapy, specifically attacking the HER2 proteins responsible for the growth and spread of cancer cells. Patients are advised to use effective contraception during treatment and for at least 7 months after the final dose to prevent pregnancy-related risks.

Herti 440mg Injection is not recommended for individuals under 18 years of age, or for those with severe breathing issues or who require oxygen therapy. Before starting treatment, inform your doctor if you have a history of heart disease, shortness of breath, or previous cancer treatments. It is essential to share a complete list of all medications, supplements, and herbal products you are using to avoid potential interactions.

Uses

  • Advanced and metastatic breast cancer
  • Metastatic gastric cancer

Directions for use

This medicine will be administered by your doctor or nurse. Please do not attempt to self-administer it.


Side effects

  • Nail disorders
  • Weight loss
  • Loss of appetite
  • Bruising
  • Dry mouth
  • Liver  inflammation
  • Muscle pain
  • Asthma/ lung disorders
  • Heart Problems
  • Allergic reactions
  • Kidney problems
  • Breathing difficulties
  • Fever
  • Visual disturbances
  • Nose bleeds or runny nose
  • Hair loss
  • Dizziness

Safety Measures

Alcohol - Speak with your doctor before consuming alcohol during treatment with Herti 440mg Injection, as safety information is limited.
Pregnancy - Do not use Herti 440mg Injection during pregnancy unless clearly instructed by your doctor. It may cause harm to the unborn baby. If you are pregnant or think you may be, consult your physician immediately.
Breastfeeding - Avoid breastfeeding while receiving Herti 440mg Injection and for at least seven months after your final dose, as the medication may harm your baby.
Liver -
Inform your physician if you have any liver conditions before starting Herti 440mg Injection. In cases of severe liver impairment, dosage adjustments may be necessary.
Kidney -
Herti 440mg Injection (Trastuzumab) has no significant direct effects on the kidneys in most patients. However, kidney function should still be monitored, especially in those with pre-existing kidney conditions or receiving other nephrotoxic drugs. Always consult your doctor before use if you have kidney problems.


Disclaimer


Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping Cost
Shop Location Assam, India

No comments found for this product. Be the first to comment!